NAT-ABIRATERONE
NAT-ABIRATERONE
Approved
DIN Number
02494132
Drug Class
Human
Market Date
Jan 18, 2021
Company
HC
natco pharma (canada) inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02494132
AIG Number0152948001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
L02BX03 ABIRATERONE
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification10:00.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
ABIRATERONE ACETATEActive
Strength: 250 MG
Monograph: ABIRATERONE ACETATE